Skip to main content

Peer Review reports

From: Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study

Original Submission
16 Jan 2023 Submitted Original manuscript
27 Jan 2023 Reviewed Reviewer Report
29 Jan 2023 Reviewed Reviewer Report - Shengyuan Yu
10 Feb 2023 Author responded Author comments - Piero Barbanti
Resubmission - Version 2
10 Feb 2023 Submitted Manuscript version 2
3 Mar 2023 Reviewed Reviewer Report - Shengyuan Yu
5 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
6 Mar 2023 Editorially accepted
23 Mar 2023 Article published 10.1186/s10194-023-01561-w

You can find further information about peer review here.

Back to article page